Having a history or current diagnosis of inflammatory disorders including liver, kidney or thyroid abnormalities, pancreatitis, any malignancy or other conditions that impact inflammatory status Patients who had regularly received omega-3 supplements during 3 months before our trial Pregnancy Lactating Menopause Patients with history of smoking (at-least 5 cigarette per day) or alcohol intake during 6 months before our trial any abnormality in PTT, PT or INR tests

Having a history or current diagnosis of inflammatory disorders including liver, kidney or thyroid abnormalities, pancreatitis, any malignancy or other conditions that impact inflammatory status Patients who had regularly received omega-3 supplements during 3 months before our trial Pregnancy Lactating Menopause Patients with history of smoking (at-least 5 cigarette per day) or alcohol intake during 6 months before our trial any abnormality in PTT, PT or INR tests